We are observing how crowdfunding is becoming an increasingly important part of the rounds in the health sector as reflected in the aforementioned newspaper, which showed how several of the most impor...
La firma de venture capital de impacto Ship2B Ventures, con sede en Barcelona, ha participado recientemente en la ronda de inversión que ha cerrado la empresa de salud digital Fosanis por valor de 10...
The round was led by Big Idea Ventures, the global alternative protein fund, the U.S. multinational Cargill Ventures, the Spanish accelerator Eatable Adventures and Tech Transfer Agrifood. With a capi...
Cara Care announced a $7M equity financing round today led by family-owned international food and nutrition manufacturer Dr. Schär AG, alongside existing investors Sabadell Asabys and Johnson & Johns...
ENDRA and CDTI Innvierte lead the new investment bringing up to €7million the total funds raised by the company in the last year, together with current investors Sabadell Asabys, Caixa Capital Risc ...
​Dialogue with investors is no easy task for entrepreneurs in the healthcare sector. We will focus more on how to negotiate a round in the health Venture Capital investor sector in this article, and...
Libera Bio has announced that it has closed its Seed Round to advance its MPN Technology® into enabling studies and towards the clinic. ​Investors include Xesgalicia, Semola Tech Ventures, ROSP Co...
Eva Pando, presidenta de Sociedad Regional de Promoción, ha declarado que “Desde el principio confiamos en el gran equipo humano de Nanovex Biotechnologies y en su capacidad de ejecución. No solo ...
AtG Therapeutics is a recently created spin-off from IDIBELL and ICO, announces its launch with a first round of financing collecting 556,000 euros, received the support of international and national ...
BIOHUB VLC ha presentado su primer vehÃculo de inversión, BIOZELL VENTURES, en la Asamblea Anual de BIGBAN, la asociación nacional de inversores privados en startups, y que comenzará sus operacion...
Grow Venture Partners, la nueva gestora de Venture Capital con sede en Barcelona, que cerró un primer fondo sobreescrito de 5M€ y que tuvo que ampliarlo a 7M, tiene el objetivo de invertir en 10 pr...
SparingVision, a genomic medicine company developing vision-saving treatments for ocular diseases, today announces that it has raised €75 million in a Series B financing. The round was co-led by Jei...